Mobile Cancer Screening Devices Market

Industry Outlook

The mobile cancer screening devices market is expected to highlight positive growth at a compounded annual growth rate (CAGR) of 5.6% during the forecast period from 2019 to 2027. The mobile cancer screening devices are well equipped with efficient ergonomic features and are less expensive in comparison to conventional screening devices. The rising prevalence of cancer worldwide and increasing demand for portable screening devices among oncologists consolidate the market’s growth for mobile cancer screening devices.

Market Synopsis

The most common cancer type in women worldwide and the burgeoning requirement of early screening to reduce the mortality rate drive the breast cancer market’s growth. According to the American Institute for Cancer Research, breast cancer is the most common type of cancer occurring in the female population worldwide. In 2018, approximately 2,088,849 cases were diagnosed for breast cancer throughout the globe. Medical device companies are actively engaged in developing mobile cancer screening devices with excellent ergonomic features, low cost, and quick turnaround time required in early screening to curb the high mortality rate associated with the disease. As per the research findings of the World Health Organization (WHO), cervical cancer is the fourth most common cancer in the female population, and in 2018, around 570,000 new cases were reported worldwide. Oncologists advocate for the use of portable colposcopes in the diagnosis of cervical cancer.

Increased public health awareness about cancer, as well as the low-cost burden associated with cancer treatment, drive up demand for specialty clinics.

Specialty clinics are spearheading the end-user segment for the mobile cancer screening devices market. The chief parameters increasing its demand are rising public health awareness pertaining to cancer and the reduced cost burden associated with cancer treatment. Hospitals will be registering impressive growth during the forecast period owing to the proactive role adopted by government healthcare agencies to fight cancer by providing huge financial aid to promote early cancer diagnosis. A large patient pool suffering from cancer can be enrolled in clinical trial studies to test the accuracy and precision of the novel mobile cancer screening device under investigation.

In North America, market growth is being driven by rising cancer prevalence and the presence of pioneering IT healthcare firms engaged in the development of mobile cancer screening devices.

North America is responsible for 34.5% of the market share and is the leading regional segment for the global mobile screening devices market. The major constituents influencing its proactive market growth are rising prevalence rates of cancer. According to the statistics brought forward by the American Cancer Society (ACS) in 2019, approximately 1,762,450 new cancer cases have been reported. The presence of pioneering IT-healthcare firms actively engaged in the development of mobile cancer screening devices further strengthens the market’s growth in the region. Europe is accountable for 29.5% on account of the high mortality rate associated with advanced-stage cancer. According to World Health Organization (WHO) research, 1.9 million people die of cancer in Europe each year as a result of delayed diagnosis and medical intervention. Asia Pacific holds a 16% market share and will be growing at a rapid pace in the near future, owing to emerging startup companies working in collaboration with major players to develop mobile cancer screening devices and a significant rise in the number of specialty clinics engaged in cancer treatment.

Periods of History and Forecast

This research report presents the analysis of each segment from 2017 to 2027, considering 2018 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2019 to 2027.

Report Scope by Segments

The market is segmented by application, end user, and geography. Medical device companies and IT healthcare firms engaged in the development of mobile cancer screening devices are AbDent, Inc., Apteryx, Inc., Breastlight, Braster S.A., Bremen Ltd., Forward Science, MobileODT Ltd., Niramai Health Analytix, TruScreen, and UE LifeSciences.

Key questions are answered in this report.

• Which IT healthcare companies are developing mobile cancer screening devices?
• What are the latest mergers, acquisitions, and collaborations happening in the mobile cancer screening devices market?
• What are the prevalence rate and mortality rate of different types of malignant cancer?
• What factors increase the popularity of specialty clinics?
• What is the market performance of mobile cancer screening devices in Europe and North America?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Application
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global MCSD Market Portraiture
2.2. Global MCSD Market, by Application, 2018 (US$ Mn)
2.3. Global MCSD Market, by End User, 2018 (US$ Mn)
2.4. Global MCSD Market, by Geography, 2018 (US$ Mn)

Chapter 3. Mobile Cancer Screening Devices (MCSD) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global MCSD Market, by Key Players, 2018

Chapter 4. Global Mobile Cancer Screening Devices (MCSD) Market, by Application
4.1. Overview
4.2. Cervical Cancer
4.3. Breast Cancer
4.4. Oral Cancer
4.5. Others

Chapter 5. Global Mobile Cancer Screening Devices (MCSD) Market, by End User
5.1. Overview
5.2. Home Care Settings
5.3. Specialty Clinics
5.4. Hospitals

Chapter 6. Global Mobile Cancer Screening Devices (MCSD) Market, by Geography
6.1. Overview
6.2. North America MCSD Market Analysis, 2017 – 2027
6.2.1. North America MCSD Market, by Application, 2017 – 2027 (US$ Mn)
6.2.2. North America MCSD Market, by End User, 2017 – 2027 (US$ Mn)
6.2.3. North America MCSD Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe MCSD Market Analysis, 2017– 2027
6.3.1. Europe MCSD Market, by Application, 2017 – 2027 (US$ Mn)
6.3.2. Europe MCSD Market, by End User, 2017 – 2027 (US$ Mn)
6.3.3. Europe MCSD Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific MCSD Market Analysis, 2017 – 2027
6.4.1. Asia Pacific MCSD Market, by Application, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific MCSD Market, by End User, 2017 – 2027 (US$ Mn)
6.4.3. Asia Pacific MCSD Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America MCSD Market Analysis, 2017 – 2027
6.5.1. Latin America MCSD Market, by Application, 2017 – 2027 (US$ Mn)
6.5.2. Latin America MCSD Market, by End User, 2017 – 2027 (US$ Mn)
6.5.3. Latin America MCSD Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa MCSD Market Analysis, 2017 – 2027
6.6.1. MEA MCSD Market, by Application, 2017 – 2027 (US$ Mn)
6.6.2. MEA MCSD Market, by End User, 2017 – 2027 (US$ Mn)
6.6.3. MEA MCSD Market, by Region, 2017– 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. AbDent, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Apteryx, Inc.
7.3. Breastlight
7.4. Braster S.A.
7.5. Bremed Ltd.
7.6. Forward Science
7.7. MobileODT Ltd.
7.8. Niramai Health Analytix
7.9. TruScreen
7.10. UE LifeSciences

List of Figures

FIG. 1 Mobile Cancer Screening Devices (MCSD) Market: Research Methodology
FIG. 2 MCSD: Market Segmentation
FIG. 3 Global MCSD Market, by Application, 2018 (US$ Mn)
FIG. 4 Global MCSD Market, by End User, 2018 (US$ Mn)
FIG. 5 Global MCSD Market, by Geography, 2018 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2018
FIG. 7 Competitive Analysis: Global MCSD Market, by Key Players, 2018
FIG. 8 Global Cervical Cancer Market for MCSD, 2017 – 2027 (US$ Mn)
FIG. 9 Global Breast Cancer Market for MCSD, 2017 – 2027 (US$ Mn)
FIG. 10 Global Oral Cancer Market for MCSD, 2017 – 2027 (US$ Mn)
FIG. 11 Global Other Applications Market for MCSD, 2017 – 2027 (US$ Mn)
FIG. 12 Global Home Care Settings Market for MCSD, 2017 – 2027 (US$ Mn)
FIG. 13 Global Specialty Clinics Market for MCSD, 2017 – 2027 (US$ Mn)
FIG. 14 Global Hospitals Market for MCSD, 2017 – 2027 (US$ Mn)
FIG. 15 U.S. MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 16 Canada MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 17 U.K. MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 18 Germany MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 19 Rest of Europe MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 20 China MCSD Market, 2017– 2027 (US$ Mn)
FIG. 21 Japan MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 22 Rest of Asia Pacific MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 23 Brazil MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 24 Mexico MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest of Latin America MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 26 GCC MCSD Market, 2017 – 2027 (US$ Mn)
FIG. 27 Rest of Middle East and Africa MCSD Market, 2017 – 2027 (US$ Mn)

List of Tables

TABLE 1 Global Mobile Cancer Screening Devices (MCSD) Market Portraiture
TABLE 2 Global MCSD Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 3 Global MCSD Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 4 Global MCSD Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America MCSD Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 6 North America MCSD Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 7 North America MCSD Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe MCSD Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 9 Europe MCSD Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 10 Europe MCSD Market, by Country/Region, 2017– 2027 (US$ Mn)
TABLE 11 Asia Pacific MCSD Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific MCSD Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific MCSD Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America MCSD Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America MCSD Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America MCSD Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa MCSD Market, by Application, 2017– 2027 (US$ Mn)
TABLE 18 Middle East and Africa MCSD Market, by End User, 2017– 2027 (US$ Mn)
TABLE 19 Middle East and Africa MCSD Market, by Region, 2017 – 2027 (US$ Mn)
TABLE 20 AbDent, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Apteryx, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Breastlight: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Braster S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Bremed Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Forward Science: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 MobileODT Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Niramai Health Analytix: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 TruScreen: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 UE LifeSciences: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)